Growth Metrics

Alx Oncology Holdings (ALXO) Cash from Investing Activities (2019 - 2026)

Alx Oncology Holdings' Cash from Investing Activities history spans 5 years, with the latest figure at -$16.7 million for Q4 2023.

  • On a quarterly basis, Cash from Investing Activities fell 252.31% to -$16.7 million in Q4 2023 year-over-year; TTM through Dec 2023 was $44.7 million, a 118.97% increase, with the full-year FY2025 number at $82.6 million, down 4.25% from a year prior.
  • Cash from Investing Activities hit -$16.7 million in Q4 2023 for Alx Oncology Holdings, down from $12.8 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for ALXO hit a ceiling of $42.3 million in Q1 2023 and a floor of -$183.9 million in Q1 2022.
  • Historically, Cash from Investing Activities has averaged -$13.0 million across 5 years, with a median of -$7000.0 in 2021.
  • The widest YoY moves for Cash from Investing Activities: up 3540.95% in 2022, down 2627342.86% in 2022.
  • Tracing ALXO's Cash from Investing Activities over 5 years: stood at $62000.0 in 2019, then plummeted by 117.74% to -$11000.0 in 2020, then crashed by 40972.73% to -$4.5 million in 2021, then soared by 342.19% to $10.9 million in 2022, then crashed by 252.31% to -$16.7 million in 2023.
  • Business Quant data shows Cash from Investing Activities for ALXO at -$16.7 million in Q4 2023, $12.8 million in Q3 2023, and $6.2 million in Q2 2023.